SurroMed is seeking to in-license additional therapeutic candidates with a focus on autoimmune and inflammatory disease. We are particularly interested in therapeutic candidates whose development or commercial success could be enhanced by application of our biomarker discovery technology.

For more information about partnering opportunities, please call us at 650.230.1591 or email us at [email protected].